Australia awards: best equity offering
When pharma firm CSL needed to raise cash to fund its takeover of a US rival it turned to Merrill Lynch. Acting alone, the bank rapidly built a top-quality order book for the follow-on offering. It helped that experts were so confident in the rationale of CSL’s acquisition.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts